Hafizal, Rabiatul Adawiyah and Shamsudin, Siti Hajar and Mohamed, Elizah and Mohd Fauzi, Noor Akhmazillah (2022) Production of insulin using recombinant DNA technology. In: CHEMICAL PROCESS AND SUSTAINABILITY IN MEDICAL BIOTECHNOLOGY. Penerbit UTHM, UTHM, pp. 29-44.
|
Text
3.pdf Download (1MB) | Preview |
Abstract
Biotechnology is a technology-related branch of biology. It has so many applications in the fields of agriculture, pharmaceutical and human medicine. Pharmaceutical biotechnology nevertheless has its cornerstones in fermentation and bioprocessing, but the paradigm shift created through biotechnology and pharmaceutical research has resulted in an up-to-date concept. The biotechnological revolution has redefined the processes of drug research, development, manufacturing and marketing. Insulin is one of the finest inventions in medical science in the field of biotechnology applications. Human insulin was formulated in the laboratory under in vitro conditions using recombinant DNA technology that is used for the treatment of a variety of diseases and is widely used in the clinical research industry. Human recombinant insulin was one of the first products of biotechnology. It has been developed in response to the need for consistent and sufficient global supply. This paper will discuss the production of human insulin formulations and the place of recombinant DNA technology in society.
| Item Type: | Book Section |
|---|---|
| Uncontrolled Keywords: | Biotechnology; pharmaceutical; recombinant DNA technology; human insulin |
| Subjects: | T Technology > T Technology (General) |
| Depositing User: | Mr. Abdul Rahim Mat Radzuan |
| Date Deposited: | 15 Aug 2022 03:08 |
| Last Modified: | 15 Aug 2022 03:08 |
| URI: | http://eprints.uthm.edu.my/id/eprint/7523 |
Actions (login required)
 |
View Item |